Search

Sreenivasan Padmanabhan

Supervisory Patent Examiner (ID: 11184, Phone: (571)272-0629 , Office: P/1627 )

Most Active Art Unit
1621
Art Unit(s)
1621, 1617, 1204, 1627
Total Applications
773
Issued Applications
622
Pending Applications
48
Abandoned Applications
103

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12057062 [patent_doc_number] => 20170333407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-23 [patent_title] => 'METHOD FOR TREATING UNDERACTIVE BLADDER SYNDROME' [patent_app_type] => utility [patent_app_number] => 15/524000 [patent_app_country] => US [patent_app_date] => 2015-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11064 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15524000 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/524000
METHOD FOR TREATING UNDERACTIVE BLADDER SYNDROME Oct 29, 2015 Abandoned
Array ( [id] => 12022161 [patent_doc_number] => 20170312260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'NEW INDICATION OF AZELNIDIPINE PHARMACEUTICAL COMPOSITION FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 15/521500 [patent_app_country] => US [patent_app_date] => 2015-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3333 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15521500 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/521500
NEW INDICATION OF AZELNIDIPINE PHARMACEUTICAL COMPOSITION FOR TREATING CANCER Oct 22, 2015 Abandoned
Array ( [id] => 10669673 [patent_doc_number] => 20160015818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-21 [patent_title] => 'COMPOSITIONS AND METHODS FOR PHYSIOLOGICAL DELIVERY USING CANNABIDIOL' [patent_app_type] => utility [patent_app_number] => 14/804125 [patent_app_country] => US [patent_app_date] => 2015-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2527 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14804125 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/804125
COMPOSITIONS AND METHODS FOR PHYSIOLOGICAL DELIVERY USING CANNABIDIOL Jul 19, 2015 Abandoned
Array ( [id] => 10365750 [patent_doc_number] => 20150250756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'METHODS OF TREATING HYPERCHOLESTEROLEMIA' [patent_app_type] => utility [patent_app_number] => 14/718986 [patent_app_country] => US [patent_app_date] => 2015-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11551 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14718986 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/718986
METHODS OF TREATING HYPERCHOLESTEROLEMIA May 20, 2015 Abandoned
Array ( [id] => 11689558 [patent_doc_number] => 20170165274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-15 [patent_title] => 'COMPOSITION' [patent_app_type] => utility [patent_app_number] => 15/125228 [patent_app_country] => US [patent_app_date] => 2015-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9808 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15125228 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/125228
COMPOSITION Mar 10, 2015 Abandoned
Array ( [id] => 9932252 [patent_doc_number] => 20150080444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'METHOD OF TREATING BENDAMUSTINE-RESPONSIVE CONDITIONS IN PATIENTS REQUIRING REDUCED VOLUMES FOR ADMINISTRATION' [patent_app_type] => utility [patent_app_number] => 14/554269 [patent_app_country] => US [patent_app_date] => 2014-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4265 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14554269 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/554269
METHOD OF TREATING BENDAMUSTINE-RESPONSIVE CONDITIONS IN PATIENTS REQUIRING REDUCED VOLUMES FOR ADMINISTRATION Nov 25, 2014 Abandoned
Array ( [id] => 9135698 [patent_doc_number] => 20130296413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'N-DESMETHYL-DOXEPIN AND METHODS OF USING THE SAME TO TREAT SLEEP DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/933975 [patent_app_country] => US [patent_app_date] => 2013-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9659 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13933975 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/933975
N-DESMETHYL-DOXEPIN AND METHODS OF USING THE SAME TO TREAT SLEEP DISORDERS Jul 1, 2013 Abandoned
Array ( [id] => 10267104 [patent_doc_number] => 20150152101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-04 [patent_title] => 'ACTIVE COMPOUNDS FOR COMBATING GREASY SKIN' [patent_app_type] => utility [patent_app_number] => 14/405969 [patent_app_country] => US [patent_app_date] => 2013-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8695 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14405969 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/405969
ACTIVE COMPOUNDS FOR COMBATING GREASY SKIN Jun 4, 2013 Abandoned
Array ( [id] => 9175061 [patent_doc_number] => 20130317046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'USE OF A DPP-4 INHIBITOR IN AUTOIMMUNE DIABETES, PARTICULARLY LADA' [patent_app_type] => utility [patent_app_number] => 13/898966 [patent_app_country] => US [patent_app_date] => 2013-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20553 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13898966 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/898966
USE OF A DPP-4 INHIBITOR IN AUTOIMMUNE DIABETES, PARTICULARLY LADA May 20, 2013 Abandoned
Array ( [id] => 9269759 [patent_doc_number] => 20140024677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'METHODS FOR INDUCING MITOCHONDRIAL BIOGENESIS' [patent_app_type] => utility [patent_app_number] => 13/859546 [patent_app_country] => US [patent_app_date] => 2013-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 20041 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13859546 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/859546
METHODS FOR INDUCING MITOCHONDRIAL BIOGENESIS Apr 8, 2013 Abandoned
Array ( [id] => 9771089 [patent_doc_number] => 20140294753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'NOVEL USE OF GANODERMIC ACIDS FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 13/854024 [patent_app_country] => US [patent_app_date] => 2013-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5366 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13854024 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/854024
NOVEL USE OF GANODERMIC ACIDS FOR TREATING CANCER Mar 28, 2013 Abandoned
Array ( [id] => 8618228 [patent_doc_number] => 20130023540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'TREATMENT OF MASTITIS' [patent_app_type] => utility [patent_app_number] => 13/624179 [patent_app_country] => US [patent_app_date] => 2012-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2053 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13624179 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/624179
TREATMENT OF MASTITIS Sep 20, 2012 Abandoned
Array ( [id] => 9512014 [patent_doc_number] => 20140148507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'PHARMACEUTICAL COMPOSITION AND SOLID GALENIC FORM HAVING A HIGH DRONEDARONE CONTENT, AND METHOD FOR PREPARING SAME' [patent_app_type] => utility [patent_app_number] => 14/131310 [patent_app_country] => US [patent_app_date] => 2012-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5662 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14131310 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/131310
PHARMACEUTICAL COMPOSITION AND SOLID GALENIC FORM HAVING A HIGH DRONEDARONE CONTENT, AND METHOD FOR PREPARING SAME Jul 5, 2012 Abandoned
Array ( [id] => 8382316 [patent_doc_number] => 20120225938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'METHOD FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/470377 [patent_app_country] => US [patent_app_date] => 2012-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 10934 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470377 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/470377
METHOD FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS May 13, 2012 Abandoned
Array ( [id] => 9198888 [patent_doc_number] => 20130338203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'TREATMENT OF ARTERIAL AGEING BY COMBINATION OF RAAS INHIBITOR AND HMG-CoA REDUCTASE INHIBITOR' [patent_app_type] => utility [patent_app_number] => 14/001816 [patent_app_country] => US [patent_app_date] => 2012-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 25121 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14001816 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/001816
TREATMENT OF ARTERIAL AGEING BY COMBINATION OF RAAS INHIBITOR AND HMG-CoA REDUCTASE INHIBITOR Feb 27, 2012 Abandoned
Array ( [id] => 8227246 [patent_doc_number] => 20120141454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie\'s Disease, Arteriosclerosis and Other Fibrotic Diseases' [patent_app_type] => utility [patent_app_number] => 13/372094 [patent_app_country] => US [patent_app_date] => 2012-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 38851 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13372094 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/372094
Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic Diseases Feb 12, 2012 Abandoned
Array ( [id] => 9331159 [patent_doc_number] => 20140057941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'Methods For Increasing Mean Corpuscular Volume' [patent_app_type] => utility [patent_app_number] => 13/977992 [patent_app_country] => US [patent_app_date] => 2012-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5916 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13977992 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/977992
Methods For Increasing Mean Corpuscular Volume Jan 12, 2012 Abandoned
Array ( [id] => 9122062 [patent_doc_number] => 20130288984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'COMBINATION' [patent_app_type] => utility [patent_app_number] => 13/978765 [patent_app_country] => US [patent_app_date] => 2012-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11009 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978765 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/978765
COMBINATION Jan 10, 2012 Abandoned
13/337614 SILICONE-BASED COMPOSITION FOR SKIN TREATMENT Dec 26, 2011 Abandoned
Array ( [id] => 7784805 [patent_doc_number] => 20120046361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'ETHYL PYRUVATE COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/214016 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3203 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046361.pdf [firstpage_image] =>[orig_patent_app_number] => 13214016 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/214016
ETHYL PYRUVATE COMPOSITIONS AND METHODS Aug 18, 2011 Abandoned
Menu